Goldman Sachs’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$166K Buy
+14,977
New +$134K ﹤0.01% 6130
2024
Q2
Sell
-1,381
Closed -$18.2K 5782
2024
Q1
$18.2K Buy
+1,381
New +$17.9K ﹤0.01% 5398
2023
Q2
Sell
-3,357
Closed -$50K 5904
2023
Q1
$50K Buy
+3,357
New +$62.3K ﹤0.01% 5553
2022
Q4
Sell
-1,426
Closed -$45K 6127
2022
Q3
$45K Sell
1,426
-1,263
-47% -$52.9K ﹤0.01% 5815
2022
Q2
$93K Sell
2,689
-21,923
-89% -$1.4M ﹤0.01% 5883
2022
Q1
$2.78M Buy
24,612
+7,000
+40% +$810K ﹤0.01% 3939
2021
Q4
$1.69M Buy
17,612
+824
+5% +$74.2K ﹤0.01% 4391
2021
Q3
$1.49M Buy
16,788
+15,575
+1,284% +$1.53M ﹤0.01% 4443
2021
Q2
$149K Buy
+1,213
New +$168K ﹤0.01% 5850
2021
Q1
Sell
-2,274
Closed -$348K 6198
2020
Q4
$348K Buy
2,274
+107
+5% +$19.2K ﹤0.01% 4815
2020
Q3
$402K Buy
+2,167
New +$355K ﹤0.01% 4596
2019
Q2
Sell
-129
Closed -$10K 5231
2019
Q1
$10K Buy
129
+99
+330% +$8.7K ﹤0.01% 5066
2018
Q4
$2K Sell
30
-34
-53% -$3.98K ﹤0.01% 5185
2018
Q3
$7K Sell
64
-14
-18% -$36.5K ﹤0.01% 5493
2018
Q2
$212K Sell
78
-405
-84% -$936K ﹤0.01% 4969
2018
Q1
$1.31M Buy
483
+389
+414% +$893K ﹤0.01% 3874
2017
Q4
$223K Buy
94
+62
+194% +$137K ﹤0.01% 5364
2017
Q3
$64K Sell
32
-551
-95% -$719K ﹤0.01% 6199
2017
Q2
$676K Buy
583
+422
+262% +$563K ﹤0.01% 4821
2017
Q1
$258K Buy
161
+3
+2% +$5.49K ﹤0.01% 5561
2016
Q4
$276K Sell
158
-43
-21% -$94.2K ﹤0.01% 5551
2016
Q3
$492K Sell
201
-27
-12% -$66.6K ﹤0.01% 5059
2016
Q2
$567K Sell
228
-57
-20% -$187K ﹤0.01% 4736
2016
Q1
$1.03M Buy
285
+123
+76% +$427K ﹤0.01% 4048
2015
Q4
$748K Buy
162
+77
+91% +$251K ﹤0.01% 4570
2015
Q3
$138K Buy
85
+48
+130% +$240K ﹤0.01% 6265
2015
Q2
$312K Buy
37
+11
+42% +$105K ﹤0.01% 5700
2015
Q1
$255K Sell
26
-120
-82% -$1.1M ﹤0.01% 5798
2014
Q4
$1.46M Sell
146
-71
-33% -$547K ﹤0.01% 4176
2014
Q3
$1.77M Sell
217
-16
-7% -$151K ﹤0.01% 4060
2014
Q2
$2.54M Buy
+233
New +$1.64M ﹤0.01% 3746

Other funds holding IMUX